Continuous Non-invasive Pulmonary Artery Pressure Monitoring In Heart Failure Patients Undergoing Submaximal Exercise

Wilfried Mullens,Stephen Rosenkranz,Faisal Sharif,Birgit Assmus,Niall G. Mahon,Tibor Kempf,Jozef Bartunek

DOI: https://doi.org/10.1016/j.cardfail.2023.10.436

IF: 6.592

2024-01-01

Journal of Cardiac Failure

Abstract:For patients with heart failure (HF), resting hemodynamics may be normal when patients are well diuresed but, upon exertion, HF symptoms become evident. Submaximal exercise testing, using the 6-minute walk test (6MWT), is an easy, inexpensive way to quantify functional capacity and is associated with HF hospitalizations and mortality. The ability to noninvasively capture pulmonary artery pressures (PAP) while undergoing 6MWT may provide a simple way to reveal hemodynamic aberrations silent at rest. SIRONA 2 was a prospective, multi-center, open-label, single-arm trial evaluating the safety and efficacy of a wireless PAP monitoring system in 70 HF patients with NYHA functional class III. The PA sensor is implanted in the right pulmonary artery which enables anterior readings with a hand-held reader (Figure 1A-B). The system provides comprehensive clinical information, including PAP, body weight, blood pressure (BP), heart rate (HR), blood oxygen saturation (SpO2), and symptoms from HF patients to their clinical team (Figure 1C). A sub-study of SIRONA 2 sought to examine the feasibility of continuously monitoring PAP during 6MWT in 15 subjects using a hands-free Reader Harness. The Reader was secured to the subjects using the Reader Harness (Figure 1D). While continuously monitoring PAP, subjects undertook an exercise PAP protocol which consists of 4 steps: (1) Subjects rested while seated for up to 5 min, (2) stood for 1 min, (3) performed the 6MWT, and (4) rested while seated for 5 min (Figure 1E). HR was derived from the PAP waveform. Additionally, subjects took BP and SpO2 before and after 6MWT and after 5 min of recovery. At the time of this writing, 7 subjects had completed 6MWT with continuous PAP and HR monitoring. Mean age was 72.3 years, 71.5% were male, mean BMI was 27.7 kg/m2, and 14.3% had EF > 50%. Subjects walked on average 338 ± 56.2 m. PAP and HR increased significantly during 6MWT and decreased significantly in the 5 min recovery (all p< 0.01). Other vitals increased with 6MWT although not significantly (Figure 1F). Maximum HR and maximum PAP both occurred at the end of the 6MWT. Measurement of PAP with a hands-free reader vest provides a unique opportunity to assess PAP while HF patients undergo submaximal exercise, both in the clinic and at home. Figure 1A: Cordella PA Sensor. Figure 1B: 3D model depicting the implant location of the Cordella PA pressure sensor which enables hands-free reader. Figure 1C: Cordella peripherals including BP cuff, pulse oximeter, weight scale, and hand-held reader. Figure 1D: Harness vest for the Cordella Reader enabling hands-free continuous PAP readings Figure 1E: Plot of average continuous PAP and heart rate changes for 7 subjects undergoing 6MWT protocol. Figure 1F: Measurements pre, post, and 5 min following 6MWT

cardiac & cardiovascular systems